Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Silverstein

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Cancer Treatment Reports|September 1, 1987
Contribution of prednisone to the effectiveness of hexamethylmelamine in multiple myelomaM M Oken, R E Lenhard, A A Tsiatis, et al.
Cancer|July 1, 1980
Moderate versus intensive chemotherapy of prognostically favorable non-Hodgkin's lymphoma: a progress reportE Z Ezdinli, W G Costello, M N Silverstein, et al.
The New England Journal of Medicine|May 19, 1988
Anagrelide: a new drug for treating thrombocytosisM N Silverstein, R M Petitt, L A Solberg, et al.
American Journal of Hematology|October 1, 1994
Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989B J Anía, V J Suman, J L Sobell, et al.
Cancer|April 1, 1984
High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myelomaR E Lenhard, M M Oken, J M Barnes, et al.
Clinical Science (London, England : 1979)|June 1, 1992
Pernicious anaemia as a risk factor for osteoporosisR Eastell, N E Vieira, A L Yergey, et al.
British Journal of Haematology|November 14, 1997
The effects of anagrelide on human megakaryocytopoiesisL A Solberg, A Tefferi, K J Oles, et al.
Blood Cells, Molecules & Diseases|January 1, 1996
Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methodsV F Fairbanks, G G Klee, G A Wiseman, et al.
Mayo Clinic Proceedings|June 1, 1990
Two families with hemoglobin Sogn, beta(A11)14 Leu----Arg, in Minnesota and Indiana: hematologic, functional, and biosynthetic featuresV F Fairbanks, R T Jones, C Head, et al.
Cancer|May 1, 1988
Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Cancer Treatment Reports|September 1, 1987
Contribution of prednisone to the effectiveness of hexamethylmelamine in multiple myelomaM M Oken, R E Lenhard, A A Tsiatis, et al.
Cancer|July 1, 1980
Moderate versus intensive chemotherapy of prognostically favorable non-Hodgkin's lymphoma: a progress reportE Z Ezdinli, W G Costello, M N Silverstein, et al.
The New England Journal of Medicine|May 19, 1988
Anagrelide: a new drug for treating thrombocytosisM N Silverstein, R M Petitt, L A Solberg, et al.
American Journal of Hematology|October 1, 1994
Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989B J Anía, V J Suman, J L Sobell, et al.
Cancer|April 1, 1984
High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myelomaR E Lenhard, M M Oken, J M Barnes, et al.
Clinical Science (London, England : 1979)|June 1, 1992
Pernicious anaemia as a risk factor for osteoporosisR Eastell, N E Vieira, A L Yergey, et al.
British Journal of Haematology|November 14, 1997
The effects of anagrelide on human megakaryocytopoiesisL A Solberg, A Tefferi, K J Oles, et al.
Blood Cells, Molecules & Diseases|January 1, 1996
Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methodsV F Fairbanks, G G Klee, G A Wiseman, et al.
Mayo Clinic Proceedings|June 1, 1990
Two families with hemoglobin Sogn, beta(A11)14 Leu----Arg, in Minnesota and Indiana: hematologic, functional, and biosynthetic featuresV F Fairbanks, R T Jones, C Head, et al.
Cancer|May 1, 1988
Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
Pageof 7